These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17518266)

  • 21. Managing psychotropic drug costs: will formularies work?
    Huskamp HA
    Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. State prescription drug price Web sites: how useful to consumers?
    Tu HT; Corey CG
    Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Financial incentives and physician prescription behavior: Evidence from dispensing regulations.
    Burkhard D; Schmid CPR; Wüthrich K
    Health Econ; 2019 Sep; 28(9):1114-1129. PubMed ID: 31264330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug product selection in Illinois: the first year's experience.
    Stewart JE; Grussing PG; Purohit AA
    Med Care; 1982 Aug; 20(8):831-42. PubMed ID: 7109752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B; Fairman KA
    Med Care; 2001 Dec; 39(12):1293-304. PubMed ID: 11717571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Providing incentives to control health care costs and remain competitive in the marketplace: a pilot study.
    Tootelian DH; Royer J; Johnson RC
    Health Mark Q; 1997; 15(2):87-99. PubMed ID: 10179452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Healthcare. A prescription for controversy.
    Markels A
    US News World Rep; 2003 Oct; 135(11):50, 52. PubMed ID: 14618748
    [No Abstract]   [Full Text] [Related]  

  • 31. National evaluation of prescriber drug dispensing.
    Munger MA; Ruble JH; Nelson SD; Ranker L; Petty RC; Silverstein S; Barton E; Feehan M
    Pharmacotherapy; 2014 Oct; 34(10):1012-21. PubMed ID: 25053590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
    Fairman KA; Motheral BR; Henderson RR
    Clin Ther; 2003 Dec; 25(12):3147-61; discussion 3144-6. PubMed ID: 14749153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription drug costs and the generic dispensing ratio.
    Liberman JN; Roebuck MC
    J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV
    Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG
    Inquiry; 1993; 30(2):189-98. PubMed ID: 8314607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point/counterpoint. The HMO pharmacy benefit. Contracted pharmacy services: the value of a carve-out PBM.
    Reissman D
    HMO; 1995; 36(4):57, 60-1. PubMed ID: 10166488
    [No Abstract]   [Full Text] [Related]  

  • 38. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Shifting the focus from cost to value: a government perspective.
    Edgar BS
    J Manag Care Pharm; 2006 Aug; 12(6 Suppl B):S11-5; quiz S24-6. PubMed ID: 17274691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Financial impact from in-office dispensing of oral chemotherapy.
    Howard A; Kerr J; McLain M; Modlin J
    J Oncol Pharm Pract; 2019 Oct; 25(7):1570-1575. PubMed ID: 30249154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.